Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000352127

Medchemexpress LLC TAS-119 | 1453099-83-6 | 98.0% | 506.36 | 25 MG
SDP

Catalog No. 5000352127
Encompass_Preferred

TAS-119 is a potent, selective, and orally active Aurora A inhibitor. It exhibits an IC50 of 1.0 nM for Aurora A and 95 nM for Aurora B. This compound has demonstrated potent antitumor activities, enhancing the antiproliferative effect of Paclitaxel in various human cancer cell lines, including drug-resistant ones.

  • Potent, selective, and orally active Aurora A inhibitor
  • IC50 of 1.0 nM for Aurora A
  • High selectivity over Aurora B (IC50 of 95 nM)
  • Demonstrates potent antitumor activities
  • Enhances antiproliferative effect of Paclitaxel
  • Induces mitotic accumulation in tumor cells
  • For research use only

Catalog No. 50-003-52127 Supplier Medchemexpress LLC Supplier No. 25MGHY137377
May include imposed supplier surcharges.
Add to Cart
Add to Cart

TAS-119 is a potent, selective, and orally active Aurora A inhibitor. It exhibits an IC50 of 1.0 nM for Aurora A and 95 nM for Aurora B. This compound has demonstrated potent antitumor activities, enhancing the antiproliferative effect of Paclitaxel in various human cancer cell lines, including drug-resistant ones.

  • Potent, selective, and orally active Aurora A inhibitor
  • IC50 of 1.0 nM for Aurora A
  • High selectivity over Aurora B (IC50 of 95 nM)
  • Demonstrates potent antitumor activities
  • Enhances antiproliferative effect of Paclitaxel
  • Induces mitotic accumulation in tumor cells
  • For research use only

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.